
Bio Break
Quick Insights into MedTech and Biotech Innovation
Welcome to Bio Break, a video series brought to you by StarFish Medical. Each episode delivers bite-sized, bio-focused insights on medical device product development and biotechnology in five minutes or less. Designed for busy innovators, Bio Break is your quick opportunity to learn something new, get inspired, and continue making an impact—all while taking a short pause in your day.
Enjoying Bio Break? Sign up to get new episodes sent to your inbox.
Watch our latest Bio Break episodes
From ELISA to At-Home COVID Tests
Nick Allan and Nigel Syrotuck reflect on highlights from ADLM in Chicago. This episode explores how diagnostics like COVID testing evolved from lab-based ELISA methods to rapid at-home lateral flow kits—and what it means for the future of diagnostic innovation.
Why ADLM Is the Most Important Lab Diagnostics Showcase
Nick and Nigel talk about the importance of ADLM 2025 in Chicago. Hear why it’s the leading laboratory diagnostics showcase
Past Episodes
-
In this episode of Bio Break, StarFish Medical experts Joris and Nick dive into the transformative concept of Continuous Analyte Monitoring (CxM) and its growing role in wearable medical devices. They discuss the value of tracking metabolic markers over time, as opposed to relying on static time-point measurements, and how this approach enhances precision in both diagnostics and treatment.
-
In this episode of Bio Break, StarFish Medical experts Joris and Nick tackle an intriguing question: can alternative bodily fluids like sweat, saliva, or urine offer viable alternatives to blood sampling for medical diagnostics? While blood remains the gold standard for clinical testing, advancements in non-invasive sampling methods are opening new possibilities, particularly in wearable devices and at-home diagnostics.
-
In this episode of Bio Break, Nick and Joris dive into the fascinating realm of biosensors, showcasing how nature’s biological processes inspire groundbreaking innovations in medical device technology. From jellyfish to fireflies, the natural world has provided invaluable tools that are transforming diagnostics and research.
-
In this episode of Bio Break, Joris van der Heijden and Nick Allan discuss an advanced category of combination devices: drug activation devices. Unlike drug delivery devices that transport medication to specific locations, drug activation devices ensure the drug becomes active precisely where it is needed in the body, reducing systemic side effects and enhancing therapeutic effectiveness.
-
Dive into the world of assay development with this informative episode of Bio Break, where Nick and Joris explore two critical concepts: Limit of Detection (LOD) and Limit of Quantification (LOQ). These terms might sound similar, but their implications for clinical diagnostics and medical devices are vastly different. Whether you’re an engineer, researcher, or product developer, this video sheds light on why both LOD and LOQ are vital in ensuring the precision and reliability of diagnostic tests.
-
In this episode of Bio Break, Joris and Nick explore the increasingly important world of drug-device combination products, discussing what they are, why they matter, and the unique challenges associated with their development. As modern pharmaceuticals become more complex, the role of engineered medical devices in delivering these therapies safely and effectively has never been more critical.
-
In this engaging episode of Bio Break, Nick and Joris dive into the complex world of platform technologies in product development, exploring the pros and cons of this widely discussed concept. From in-vitro diagnostics to point-of-care instruments, the term "platform" often sparks excitement—and sometimes hesitation. But what does it truly mean to build a platform-based product, and when does it make sense?
-
Nick and Joris dive into the surprising connection between rock bands and medical device safety. What do jelly beans and 1980s rock legends Van Halen have to do with developing safe and effective medical technologies? More than you might think.
-
Nick and Joris tackle a topic that’s more relevant than ever—raising funds for medical device development in today’s challenging financial landscape. With economic headwinds and cautious investors, startups and even established organizations face significant hurdles in securing funding. But there are ways to mitigate these challenges, and Joris shares strategic insights to align product development milestones with fundraising cycles.